Spontaneous conception following GnRHa and progestogen therapy in adenomyosis

References

1. Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod BioMed Online 2012;24:35–46.10.1016/j.rbmo.2011.10.003Search in Google Scholar

2. Matalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gyn 2005;17:261–4.10.1097/01.gco.0000169103.85128.c0Search in Google Scholar

3. Ota H, Igarashi S, Maki M. Distribution of tissue macrophages in uterine muscle layers in patients with adenomyosis. Med Sci Res 1991;19:473–4.Search in Google Scholar

4. Kelton T, Peter R. Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment. Aus NZ J Obstet Gynaec 2011;51:280–3.10.1111/j.1479-828X.2010.01276.xSearch in Google Scholar

5. Khan KN, Kitajima M, Hiraki K, Sekine I, Ishimaru T, Masuki H. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod 2010;25:642–53.10.1093/humrep/dep437Search in Google Scholar

6. Hirata JD, Moghissi KS, Ginsburg KA. Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:444–5.10.1016/S0015-0282(16)55703-3Search in Google Scholar

7. Al Jama FE. Management of adenomyosis in subfertile women and pregnancy outcome. Oman Med J 2011;26:178–81.10.5001/omj.2011.43Search in Google Scholar

8. Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod BioMed Online 2011;22:94–9.10.1016/j.rbmo.2010.09.014Search in Google Scholar

9. Wang PH, Yang TS, Lee WL, Chao HT, Chang SP, Yuan CC. Treatment of infertile women with adenomyosis with a conservative microsurgical technique and a gonadotropin-releasing hormone agonist. Fertil Steril 2000;73:1061–2.10.1016/S0015-0282(00)00411-8Search in Google Scholar

10. Huang WH, Yang TS, Yuan CC. Successful pregnancy after treatment of deep adenomyosis with cytoreductive surgery and subsequent gonadotropin-releasing hormone agonist: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61: 726–9.Search in Google Scholar

11. Ozaki T, Takahashi K, Okada M, Kurioka H, Miyazaki K. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int J Fertil Women M 1999;44:260–4.Search in Google Scholar

12. Yamanaka A, Kimura F, Kishi Y, Takahashi K, Suginami H, Shimizu Y, Murakami T. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells. Eur J Obstet Gyn R B 2014;179: 170–4.10.1016/j.ejogrb.2014.05.031Search in Google Scholar PubMed

13. Omar MH, Mashita MK, Lim PS, Jamil MA. Dydrogesterone in threatened abortion: Pregnancy outcome. J Steroid Biochem Mol Biol 2005;97:421–5.10.1016/j.jsbmb.2005.08.013Search in Google Scholar PubMed

14. Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol 2012;28:983–90.10.3109/09513590.2012.702875Search in Google Scholar PubMed PubMed Central